Research ArticleSpecial Contribution
SUV: Standard Uptake or Silly Useless Value?
John W. Keyes
Journal of Nuclear Medicine October 1995, 36 (10) 1836-1839;
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
SUV: Standard Uptake or Silly Useless Value?
John W. Keyes
Journal of Nuclear Medicine Oct 1995, 36 (10) 1836-1839;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Generation of synthetic TSPO PET maps from structural MRI images
- Trapping of Nicotinic Acetylcholine Receptor Ligands Assayed by In Vitro Cellular Studies and In Vivo PET Imaging
- Trapping of Nicotinic Acetylcholine Receptor Ligands Assayed by in vitro Cellular Studies and in vivo PET Imaging
- Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [18F]FDG Positron Emission Tomography
- Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism
- Reply to E. Laffon et al.
- The Influence of Minimal Misalignment on the Repeatability of PET Images Examined by the Repositioning of Point Sources
- Prognostic Value of Standardized Uptake Ratio in Patients with Trimodality Treatment of Locally Advanced Esophageal Carcinoma
- Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease
- Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis
- Repeatability of SUV in Oncologic 18F-FDG PET
- Determining the Minimal Required Radioactivity of 18F-FDG for Reliable Semiquantification in PET/CT Imaging: A Phantom Study
- Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study
- Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma
- Reply: Comment on: "Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT"
- Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET
- 18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
- Whiskers Area as Extracerebral Reference Tissue for Quantification of Rat Brain Metabolism Using 18F-FDG PET: Application to Focal Cerebral Ischemia
- Value of 4-Dimensional 18F-FDG PET/CT in the Classification of Pulmonary Lesions
- Effects of Administration Route, Dietary Condition, and Blood Glucose Level on Kinetics and Uptake of 18F-FDG in Mice
- Incidental Focal 18F-FDG Uptake in the Pituitary Gland: Clinical Significance and Differential Diagnostic Criteria
- Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine, and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors
- Dynamic PET Denoising with HYPR Processing
- Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung
- Evaluation of the Accumulation of 11C-Methionine with Standardized Uptake Value in the Normal Brain
- SUV: From Silly Useless Value to Smart Uptake Value
- Scan-Time Reduction Using Noise-Matched Images in 2- and 3-Dimensional Bismuth Germanate PET/CT: Clinical Study in Head and Neck Cancer
- Standards for PET Image Acquisition and Quantitative Data Analysis
- Measuring Response with FDG-PET: Methodological Aspects
- Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
- Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus
- Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
- Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus
- Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
- Findings on 18F-FDG PET Scans After Neoadjuvant Chemoradiation Provides Prognostic Stratification in Patients with Locally Advanced Rectal Carcinoma Subsequently Treated by Radical Surgery
- Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer
- PET for response assessment in oncology: radiotherapy and chemotherapy
- Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
- The Diabetic Foot: Initial Experience with 18F-FDG PET/CT
- Effects of Noise, Image Resolution, and ROI Definition on the Accuracy of Standard Uptake Values: A Simulation Study
- Understanding the Standardized Uptake Value, Its Methods, and Implications for Usage
- Comparison of Methods to Quantitate 18F-FDG Uptake with PET During Experimental Acute Lung Injury
- In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia
- Simplified Kinetic Analysis of Tumor 18F-FDG Uptake: A Dynamic Approach
- Quantification of 18F-FDG Uptake in Non-Small Cell Lung Cancer: A Feasible Prognostic Marker?
- Within-Patient Variability of 18F-FDG: Standardized Uptake Values in Normal Tissues
- Clinical Implications of Different Image Reconstruction Parameters for Interpretation of Whole-Body PET Studies in Cancer Patients
- Respiratory Gating for 3-Dimensional PET of the Thorax: Feasibility and Initial Results
- Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
- SUV Varies with Time After Injection in 18F-FDG PET of Breast Cancer: Characterization and Method to Adjust for Time Differences
- Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C-Methionine PET, Correlation with Morphologic Response, and Clinical Outcome
- L-1-11C-Tyrosine PET in Patients with Laryngeal Carcinomas: Comparison of Standardized Uptake Value and Protein Synthesis Rate
- Clinical 18F-FDG Oncology Patient Preparation Techniques
- Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma
- Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET
- Measurement of Perfusion in Stage IIIA-N2 Non-Small Cell Lung Cancer Using H215O and Positron Emission Tomography
- Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules
- Imaging in lung cancer: positron emission tomography scan
- 18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected Non-Small Cell Lung Cancer
- Predictive Impact of 2-18Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography for Residual Postchemotherapy Masses in Patients With Bulky Seminoma
- Increased Metabolic Activity in the Thymus Gland Studied with 18F-FDG PET: Age Dependency and Frequency After Chemotherapy
- The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
- The Diagnostic Utility of the Lognormal Behavior of PET Standardized Uptake Values in Tumors
- Lung Cancer Proliferation Correlates with [F-18]Fluorodeoxyglucose Uptake by Positron Emission Tomography
- Positron Emission Tomography Using [18F]-Fluorodeoxy-D-Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
- Imaging Brain Tumor Proliferative Activity with [124I]Iododeoxyuridine